Trial · NCT07897929
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Changes of chair rise test performance | Changes in the 5tStS from the baseline measurement to the 16-week follow-up (FU) assesment | Time for the 5 times sit to stand test (5tSTS) in s |
| Primary | Changes in static balance performance | Changes in balance performance from the baseline measurement to the 16-week follow-up (FU) assessment. | Balance performance applying the modified balance test based on the Short Physical Performance Battery (SPPB). Score from 0-4 with higher values indicationg better static balance |
| Secondary | Changes in the timed up and go test (TUG) | Changes in the TUG test results from the baseline measurement to the 16-week follow-up. | TUG: Time needed to stand up, walk 3 meters, turn, return, and sit down (in s) |
| Secondary | Changes in habitual walking speed | Changes in the habitual walking speed from the baseline measurement to the 16-week follow-up. | Habitual walking speed over 10 metres, measured using photoelectric sensors (in s) |
| Secondary | Changes in maximum strength of the hip- and leg-extensors | Changes in the isokinetic maximum strength of the hip- and leg-extensors from the baseline measurement to the 16-week follow-up. | Isokinetic maximum strength of the hip- and leg-extensors as determined by an isokinetic leg press (NM) |
| Secondary | Change in maximum trunk extensors strength | Change in the maximum isometric strength of the trunk extensors from the baseline measurement to the 16-week follow-up. | Maximum isometric strength of the trunk extensors (kg) as determined by a Dr. Wolff BackCheck |
| Secondary | Changes in fear of falling | Change in FES I from the baseline measurement to the 16-week follow-up. | Fear of falling as determined by the "Short Falls Efficacy Scale-International" (FES I). 7 Items, Score from 7-28, with higher scores indicating higher concerns of falling |
| Secondary | Changes in bone formation biomarkers | Change in PINP from the baseline measurement to the 16-week follow-up. | Changes in the bone formation marker "Procollagen Type I N-terminal Propeptide" (PINP, ng/ml)) as determined by Enzyme-Linked Immunosorbent Assay (ELISA). Note: Only in women not receiving medication for osteoporosis |
| Secondary | Changes in bone resorption biomarkers | Change in CTX from the baseline measurement to the 16-week follow-up. | Changes in the bone resorption marker "C-terminal telopeptide of type I collagen" (CTX, ng/ml) as determined by Enzyme-Linked Immunosorbent Assay (ELISA). Note: Only in women not receiving medication for osteoporosis |
| Secondary | Changes in fat free mass | Change in FFM from the baseline measurement to the 16-week follow-up. | Fat free mass (FFM, kg, g) as determined by Bioelectrical Impedance Analysis (BIA) |
| Secondary | Changes in total body fat rate | Changes in total body fat rate from the baseline measurement to the 16-week follow-up. | Total body fat rate (%) as determined by Bioelectrical Impedance Analysis (BIA) |
| Secondary | Changes in bone structure (Broadband Ultrasound Attenuation ) | Changes in BUA from the baseline measurement to the 16-week follow-up. | Bone structure as determined by Broadband Ultrasound Attenuation (BUA, dB/MHz) at the calcaneus site using an quantitative ultrasound system (QUS) |
| Secondary | Changes in bone structure (Speed of Sound ) | Changes in SOS from the baseline measurement to the 16-week follow-up. | Bone structure as determined by Speed of Sound (SOS, m/s) at the calcaneus site using an quantitative ultrasound system (QUS) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07897929/registered